[1] 唐运萍,刘艳,黄志华等.儿童自身免疫性肝炎2例临床分析及文献复习.临床儿科杂志,2017,35:13-15. [2] 王嘉鑫,程娜,葛善飞等.自身免疫性肝炎与药物性肝病血生化及病理特征的比较.广东医学,2018,39:3359-3362. [3] 王绮夏,蒋翔,连敏等.2015年欧洲肝病学会临床实践指南:自身免疫性肝炎.临床肝胆病杂志,2015,31:2000-2019. [4] 中华医学会肝病学分会,中华医学会消化病学分会,中华医学会感染病学分会等.自身免疫性肝炎诊断和治疗共识(2015).中华肝脏病杂志,2016,24:23-35. [5] Pauly MP, Tucker LY, Szpakowski JL, et al. Incidence of hepatitis B virus reactivation and hepatotoxicity in patients receiving long-term treatment with tumor necrosis factor antagonists. Clin Gastroenterol Hepatol, 2018,16:1964-1973. [6] Chaouali M, Azaiez MB, Tezeghdenti A, et al. Association of TNF-α-308 polymorphism with susceptibility to autoimmune hepatitis in tunisians. Biochem Genet, 2018,56:650-662. [7] 蒋依娜,王越,吕毅等.自身免疫性肝炎的病理学特点及肝移植疗效.中华消化外科杂志,2016,15:477-481. [8] 谭朝霞,唐玉兰,高燕等.自身抗体在乙型病毒性肝炎和自身免疫性肝炎中的特点分析.第三军医大学学报,2016,38:1762-1766. [9] Bolia R, Rajanayagam J, Hardikar W, et al. Lower 6-MMP/6-TG ratio may be a therapeutic target in pediatric autoimmune hepatitis. J Pediatr Gastroenterol Nutr, 2018,67:695-700. [10] Beringer A, Miossec P. IL-17 and IL-17-producing cells and liver diseases, with focus on autoimmune liver diseases. Autoimmun Rev, 2018,17:1176-1185. |